Spero Therapeutics SPRO
NASDAQ SPRO
$1.02 +0.01 (+0.99%)
At close: Nov 11, 2026 · 4:00 PM EST

Spero Therapeutics (SPRO) Return on Equity [ROE] (2017 - 2026)

Updated

Spero Therapeutics (SPRO) posted Return on Equity [ROE] of 15.22% for Q2 2026, up 176.22 percentage points from -161.00% a year earlier but down 12.01 percentage points from the prior quarter.

Analysis

Spero Therapeutics (SPRO) Return on Equity [ROE] (2017 - 2026) Analysis & Trends

For FY2025, Spero Therapeutics' Return on Equity [ROE] came in at 16.36%, up 106.02 percentage points from FY2024.

  • Annual Return on Equity [ROE] shows a five-year change of +92.13 percentage points (FY2020 to FY2025).
  • In prior years, Spero Therapeutics' Return on Equity [ROE] was -89.66% in FY2024 (-114.61 pp), 24.95% in FY2023 (+81.47 pp), -56.53% in FY2022 (+24.99 pp) and -81.51% in FY2021 (-5.74 pp).
  • Quarterly Return on Equity [ROE] has run from a low of -299.59% in Q3 2022 to a high of 28.42% in Q4 2023 over five years.
  • On a year-over-year basis, Return on Equity [ROE] has increased in each of the last three quarters, with an average year-over-year change of -19.21 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for Return on Equity [ROE] in the past five years was Q3 2023, with a gain of 296.61 percentage points; the weakest was Q3 2022, with a drop of 221.33 percentage points.
  • According to Business Quant data, Return on Equity [ROE] for the three prior quarters was 27.23% (Q1 2026), 19.99% (Q4 2025) and -148.01% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 74.39%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 19.33%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 5.63%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 21.60%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 72.13%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -31.17%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 4.66%
10 Spero Therapeutics 58.73 Mn -137.06 Mn - 15.22%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 15.22%
Mar 31, 2026 27.23%
Dec 31, 2025 19.99%
Sep 30, 2025 -148.01%
Jun 30, 2025 -161.00%
Mar 31, 2025 -174.76%
Dec 31, 2024 -122.99%
Sep 30, 2024 4.74%
Jun 30, 2024 19.69%
Mar 31, 2024 23.03%
Dec 31, 2023 28.42%
Sep 30, 2023 -2.98%
Jun 30, 2023 -16.86%
Mar 31, 2023 -38.15%
Dec 31, 2022 -85.62%
Sep 30, 2022 -299.59%
Jun 30, 2022 -230.33%
Mar 31, 2022 -136.91%
Dec 31, 2021 -89.72%
Sep 30, 2021 -78.26%
API Access

Spero Therapeutics Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=SPRO&period=max&api_key=YOUR_API_KEY